Bone Health Technologies has developed Osteoboost, the first FDA-cleared drug-free prescription device that utilizes targeted mechanical vibration therapy to significantly reduce bone density and strength loss in postmenopausal women with osteopenia. This wearable therapy stimulates the body's natural bone remodeling process, providing a safe and effective alternative to traditional pharmacological treatments.
Funding
Funding not disclosed
Founders
Product
Problem
Postmenopausal women with osteopenia face a significant risk of bone density and strength loss, potentially leading to osteoporosis and fractures. Traditional pharmacological treatments can have side effects, creating a need for safe and effective alternatives. Current approaches often fail to adequately address the underlying bone remodeling process.
Solution
Osteoboost is an FDA-cleared, drug-free prescription medical device that utilizes targeted mechanical vibration therapy to reduce bone density and strength loss in postmenopausal women diagnosed with osteopenia. Inspired by NASA research, the wearable device delivers a proprietary combination of vibration frequency and amplitude to stimulate the body's natural bone remodeling process. The therapy is administered in 30-minute daily sessions and is designed to be easy and pain-free. Clinical trials have demonstrated significant reductions in the loss of both bone density and bone strength in the spine, with high patient compliance and minimal reported side effects.
Target Audience
The primary audience includes postmenopausal women with osteopenia seeking a safe, effective, and drug-free alternative to traditional treatments for bone density loss, as well as their healthcare providers (physicians and other practitioners) who treat them.
Features
- Wearable belt design for convenient, at-home use
- Targeted mechanical stimulation focused on the hips and lumbar spine
- Proprietary combination of vibration frequency and amplitude
- Clinically proven to reduce the loss of vertebral bone density and bone strength
- Companion app offering exercise programs, tracking tools, and support
- Non-pharmacological approach, avoiding potential side effects of drug treatments
- High patient compliance with a simple 30-minute daily session